Venker Eric
- SEC CIK
- 0001801917
In the past year, 16 open-market sale filings worth $90.2M and no purchases.
Current role at each company
- ROIV Roivant Sciences Ltd.President & Immunovant CEOas of Sep 1, 2026
- IMVT Immunovant, Inc.Chief Executive Officeras of Jul 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $90.2M
- 16 filings
- Net
- −$90.2M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Venker Eric as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ROIV Roivant Sciences Ltd.
President & Immunovant CEO57 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 (view filing) | Mar 25 | 4 days | Venker EricPresident & COO | SSale | −80.0K | $5.06 | −$405.0K | −5.8%1.31M after | |
| Apr 1, 2022 (view filing) | Mar 30 | 2 days | Venker EricPresident & COO | SSale | −19.3K | $4.84 | −$93.6K | −1.5%1.29M after | |
| Apr 27, 2022 (view filing) | Apr 25 | 2 days | Venker EricPresident & COO | SSale | −5.11K | $3.84 | −$19.6K | −0.4%1.27M after | |
| May 24, 2022 (view filing) | May 20 | 4 days | Venker EricPresident & COO | SSale | −136.4K | $3.70 | −$504.8K | −10.7%1.13M after | |
| Jun 27, 2022 (view filing) | Jun 23 | 4 days | Venker EricPresident & COO | SSale | −16.4K | $4.34 | −$71.2K | −1.4%1.12M after | |
| Jul 27, 2022 (view filing) | Jul 25 | 2 days | Venker EricPresident & COO | SSale | −16.9K | $4.33 | −$73.2K | −1.5%1.10M after | |
| Aug 26, 2022 (view filing) | Aug 24 | 2 days | Venker EricPresident & COO | SSale | −16.5K | $3.71 | −$61.3K | −1.5%1.08M after | |
| Sep 27, 2022 (view filing) | Sep 23 | 4 days | Venker EricPresident & COO | SSale | −17.4K | $3.07 | −$53.4K | −1.6%1.07M after | |
| Oct 27, 2022 (view filing) | Oct 25 | 2 days | Venker EricPresident & COO | SSale | −15.9K | $4.40 | −$70.1K | −1.5%1.05M after | |
| Dec 9, 2022 (view filing) | Dec 8-9 | 1 day | Venker EricPresident & COO | SSale | −145.1K | $7.03 | −$1.02M | −14.0%888.7K after | 2 lots |
IMVT Immunovant, Inc.
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2026 (view filing) | Apr 2 | 1 day | Venker EricChief Executive Officer | SSale | −14.2K | $24.10 | −$342.9K | −42.1%19.6K after | 2 lots |
| Jul 6, 2026 (view filing)5:01 PM ET | Jul 2 | 4 days | Venker EricChief Executive Officer | SSale | −3.09K | $38.48 | −$119.0K | −1.2%254.3K after |